PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
K-STREET TRACKER

FOLLOW THE MONEY INTO THE SWAMP

Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.

Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies

💸 Top Spending Clients

🎯 Top Lobbied Tickers

#TickerFilingsTotal $
1META
Meta Platforms Inc.
129$50.2M
2PFE
Pfizer Inc.
87$48.6M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
46$37.7M
5AMZN
Amazon.com Inc.
80$35.3M
6LMT
Lockheed Martin Corporation
88$29.4M
7FDX
FedEx Corporation
82$28.3M
8LLY
Eli Lilly and Company
83$28.1M
9AMGN
Amgen Inc.
95$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
64$26.8M
12GOOGL
Alphabet Inc. Class A
123$26.6M
13MO164$26.2M
14SO
Southern Company
108$26.1M
15UNH
UnitedHealth Group Inc.
67$23.9M
16VZ
Verizon Communications Inc.
116$23.8M
17TMUS159$22.7M
18CHTR137$22.6M
19GD
General Dynamics Corporation
127$22.5M
20T
AT&T Inc.
134$21.6M
21ORCL
Oracle Corporation
132$20.6M
22CMCSA
Comcast Corporation
141$20.4M
23CI
The Cigna Group
64$19.9M
24OXY
Occidental Petroleum Corporation
36$19.9M
25MSFT
Microsoft Corporation
122$19.2M

🆕 Filtered Filings · RMD

clear filters
DateTickerClientRegistrantAmountIssue
2026-04-20RMDRESMED CORP.AKIN GUMP STRAUSS HAUER & FELD$110KIssues related to Section 232 investigation on medical devices.
2026-04-20RMDRESMED CORP.ICE MILLER LLP$40KIssues related to ResMed. Issues related to ResMed. Issues related to ResMed. Issues related to ResMed.
2026-01-20RMDRESMED CORP.AKIN GUMP STRAUSS HAUER & FELD$90KIssues related to respiratory care in the Medicare program; Issues related to Medicare proposed rule for competitive bidding of Durable Medical Equipment (DME). Issues related to respiratory care market and patient outcomes. Issues related to Section 232 investigation on medical devices.
2026-01-20RMDRESMED CORP.ICE MILLER LLP$40KIssues related to ResMed. Issues related to ResMed. Issues related to ResMed. Issues related to ResMed.
2025-10-20RMDRESMED CORP.AKIN GUMP STRAUSS HAUER & FELD$20KIssues related to respiratory care in the Medicare program; Issues related to Medicare proposed rule for competitive bidding of Durable Medical Equipment (DME).
2025-10-20RMDRESMED CORP.ICE MILLER LLP$0Issues related to ResMed. Issues related to ResMed. Issues related to ResMed. Issues related to ResMed.
2025-10-16RMDRESMED CORP.DLA PIPER LLP (US)$40KIssues related to medical devices and healthcare policy. Supply chain issues.
2025-10-03RMDRESMED CORP.ICE MILLER LLP$0Issues related to ResMed Corp. Issues related to ResMed Corp. Issues related to ResMed Corp. Issues related to ResMed Corp.
2025-07-21RMDRESMED CORP.DLA PIPER LLP (US)$60KIssues related to medical devices and healthcare policy. Supply chain issues.
2025-07-21RMDRESMED CORP.AKIN GUMP STRAUSS HAUER & FELD$0
2025-04-21RMDRESMED CORP.DLA PIPER LLP (US)$60KIssues related to medical devices and healthcare policy. Supply chain issues.
2025-04-21RMDRESMED CORP.AKIN GUMP STRAUSS HAUER & FELD$0
2025-01-21RMDRESMED CORP.DLA PIPER LLP (US)$60KIssues related to medical devices and healthcare policy. Supply chain issues.
2025-01-21RMDRESMED CORP.AKIN GUMP STRAUSS HAUER & FELD$0